← FDA Drug Approvals (Drugs@FDA)

LITFULO

NDA · New Drug Application · Sponsor: PFIZER · Approved 2023-06-23

Drug application

FDA Application #

NDA215830

Application type

New Drug Application

Brand name

LITFULO

Generic name

RITLECITINIB

Active ingredients

RITLECITINIB TOSYLATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

PFIZER

Manufacturer

Pfizer Laboratories Div Pfizer Inc

First approval

2023-06-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown